학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 348건 | 목록 1~20
Academic Journal
Ludwig H; Department of Medicine, Center for Oncology, Hematology and Palliative Care, Wilhelminen Cancer Research Institute, Wilhelminen Hospital, Vienna, Austria.; Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Boccadoro M; European Myeloma Network, EMN, Torino, Italy.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Martínez S; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Kahatt C; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Jiménez J; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Nieto A; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Extremera S; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Gómez J; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Alfaro V; Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain.; Davi R; Medidata AI , Medidata Solutions, a Dassault Systèmes Company, New York, U.S.; Yin X; Medidata AI , Medidata Solutions, a Dassault Systèmes Company, New York, U.S.; Mateos MV; Departamento de Hematología, Hospital Universitario de Salamanca. Paseo de San Vicente, Salamanca, 58-182. 37007, Spain. mvmateos@usal.es.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process
Academic Journal
Falcón A; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain. afalconglez@gmail.com.; Ponce S; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Cote GM; Mass General Cancer Center, Boston, MA, USA.; Gil A; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain.; Lin JJ; Mass General Cancer Center, Boston, MA, USA.; Bockorny B; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Martínez J; Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, S/N, 41013, Seville, Spain.; Kahatt C; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Martinez S; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Zubiaur P; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Siguero M; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Cullell-Young M; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Jiménez J; Pharma Mar, Colmenar Viejo, Madrid, Spain.; Zugazagoitia J; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Paz-Ares L; Hospital Universitario, 12 de Octubre, Madrid, Spain.; CNIO-H12O Lung Cancer Clinical Cancer Research Unit, Instituto de Investigación Biomédica I+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; CIBERONC, Madrid, Spain.; Universidad Complutense, Madrid, Spain.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Mateos MV; Department of Hematology, University Hospital of Salamanca/IBSAL, 37007 Salamanca, Spain.; Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.; Martínez S; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Kahatt C; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Jiménez J; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Extremera S; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Gómez J; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Alfaro V; Clinical R&D, PharmaMar, Colmenar Viejo, 28770 Madrid, Spain.; Ludwig H; Wilhelminen Cancer Research Institute, Department of Medicine, Center for Oncology, Hematology and Palliative Care, Wilhelminen Hospital, 1160 Vienna, Austria.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
J Clin Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
JOURNAL OF CLINICAL ONCOLOGY
Academic Journal
Ghalib MH; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Now at Rutgers Cancer Institute, New Brunswick, NJ, USA.; Pulla MP; Dept. Servicio de Oncología Médica, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.; De Miguel Luken MJ; Early Phase Clinical Trial Unit, Hospital Madrid Norte San Chinarro - Centro Integral Oncologico Clara Campal, Madrid, Spain.; de Juan VC; Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain.; Chaudhary I; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Hammami MB; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Vikash S; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Maitra R; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Martinez S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain.; Kahatt C; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain.; Extremera S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain.; Fudio S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain.; Goel S; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA. sanjay.goel@rutgers.edu.; Now at Rutgers Cancer Institute, New Brunswick, NJ, USA. sanjay.goel@rutgers.edu.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Conference
Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Cote GM; Center for Sarcoma and Connective Tissue Oncology, Mass General Cancer Center, Boston, Massachusetts, USA.; Chawla SP; Cancer Center of Southern California, Sarcoma Oncology Center, Santa Monica, California, USA.; Demetri G; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Kasper B; Sarcoma Unit, Mannheim University Medical Center (UMM), Mannheim, Germany.; Jones RL; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.; Broto JM; Department of Medical Oncology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Wooley J; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio, USA.; Weiss MC; Division of Medical Oncology, Washington University School of Medicine in St. Louis, St Louis, Missouri, USA.; Tafuto S; Sarcomas and Rare Tumors Unit, Istituto Nazionale dei Tumori IRCCS Fondazione 'G Pascale', Napoli, Italy.; Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, A. O. U. P. Paolo Giaccone, Palermo, Italy.; Carrasco I; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Peinado P; HM CIOCC MADRID (Centro Integral Oncológico Clara Campal), HM Sanchinarro, Madrid, Spain.; Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Boggio G; Clinical R&D, PharmaMar, Colmenar, Viejo, Spain.; Fernandez C; Clinical R&D, PharmaMar, Colmenar, Viejo, Spain.; Nieto A; Clinical R&D, PharmaMar, Colmenar, Viejo, Spain.; Kahatt C; Clinical R&D, PharmaMar, Colmenar, Viejo, Spain.; Alfaro V; Clinical R&D, PharmaMar, Colmenar, Viejo, Spain.; Le Cesne A; Department of Medical Oncology, Institut Gustave Roussy, Paris, France.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Kristeleit R; University College London Cancer Institute, NIHR UCLH Clinical Research Facility and Guy's and St Thomas' NHS Foundation Trust, London, UK.; Leary A; Institut Gustave Roussy, Villejuif, France.; Delord JP; Institut Claudius Regaud, Toulousse, France.; Moreno V; START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Oaknin A; Gynecologic Cancer Programme; Vall d'Hebrón Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebrón, Barcelona, Spain.; Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain.; Shappiro GI; Dana-Farber Cancer Institute, Boston, MA, USA.; Fernández C; PharmaMar, Colmenar Viejo, Spain.; Kahatt C; PharmaMar, Colmenar Viejo, Spain.; Alfaro V; PharmaMar, Colmenar Viejo, Spain.; Siguero M; PharmaMar, Colmenar Viejo, Spain.; Rueda D; PharmaMar, Colmenar Viejo, Spain.; Zeaiter A; PharmaMar, Colmenar Viejo, Spain.; Awada A; Institut Jules Bordet, HUB, Université Libre De Bruxelles, Brussels, Belgium.; Santaballa A; Hospital La Fe, Valencia, Spain.; Zaman K; University Hospital CHUV, Lausanne, Switzerland.; Sehouli J; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, USA. Vivek.Subbiah@scri.com.; Sarah Cannon Research Institute, 1100 Dr. Martin L. King Jr. Blvd., Suite 800, Nashville, TN, 37203, USA. Vivek.Subbiah@scri.com.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Peters S; Department of Oncology, University Hospital CHUV, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.; Trigo J; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.; Besse B; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; Moreno V; Department of Medical Oncology, START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Navarro A; Department of Medical Oncology, Vall d'Hebrón Institute of Oncology, Barcelona, Spain.; Eugenia Olmedo M; Department of Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain.; Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Grohé C; Klinik für Pneumologie, Evangelische Lungenklinik Berlin, Berlin, Germany.; Antonio Lopez-Vilariño J; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Fernández C; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Kahatt C; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Alfaro V; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Nieto A; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Zeaiter A; Clinical R&D, PharmaMar, Colmenar Viejo, Spain.; Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, TN, USA.
Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Academic Journal
Calvo E; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain.; Sessa C; Oncology Institute of Southern Switzerland, EOC, Ospedale San Giovanni, Bellinzona, Switzerland.; Harada G; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.; de Miguel M; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain.; Kahatt C; PharmaMar, Colmenar Viejo, Madrid, Spain.; Luepke-Estefan XE; PharmaMar, Colmenar Viejo, Madrid, Spain.; Siguero M; PharmaMar, Colmenar Viejo, Madrid, Spain.; Fernandez-Teruel C; PharmaMar, Colmenar Viejo, Madrid, Spain.; Cullell-Young M; PharmaMar, Colmenar Viejo, Madrid, Spain.; Stathis A; Oncology Institute of Southern Switzerland, EOC, Ospedale San Giovanni, Bellinzona, Switzerland.; Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. drilona@mskcc.org.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Leary A; Gustave Roussy Cancer Campus, Villejuif, France.; Oaknin A; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quirón, UVic-UCC, Barcelona, Spain.; Trigo JM; Hospital Universitario Virgen de la Victoria, Málaga, Spain.; Moreno V; START Madrid - FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Boni V; NEXT Madrid, Universitary Hospital QuironSalud Madrid, Madrid, Spain; START Madrid - HM CIOCC, Hospital Madrid Norte Sanchinarro, Madrid, Spain.; Braña I; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quirón, UVic-UCC, Barcelona, Spain.; Fernández C; PharmaMar, Colmenar Viejo, Madrid, Spain.; Kahatt C; PharmaMar, Colmenar Viejo, Madrid, Spain.; Nieto A; PharmaMar, Colmenar Viejo, Madrid, Spain.; Cullell-Young M; PharmaMar, Colmenar Viejo, Madrid, Spain.; Zeaiter A; PharmaMar, Colmenar Viejo, Madrid, Spain.; Subbiah V; Sarah Cannon Research Institute, Nashville, Tennessee, USA. Electronic address: Vivek.Subbiah@scri.com.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Br J Cancer
Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, De Miguel, B, Cullell-Young, M & Calvert, H 2013, 'Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma', British Journal of Cancer, vol. 109, no. 6, pp. 1451-1459. https://doi.org/10.1038/bjc.2013.477
검색 결과 제한하기
제한된 항목
[검색어] Kahatt, C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어